Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
- Status
- COMPLETED
- Phase
- PHASE1
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Personalized NK Cell Therapy in CBT
- Status
- RECRUITING
- Phase
- PHASE2
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PLX51107 in Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1